Home » Topics » Regulatory

Regulatory
RSS

FDA approves PrandiMet, a repaglinide and metformin fixed-dose tablet

June 26, 2008

The FDA approves Lilly's Cymbalta for fibromyalgia

June 17, 2008

Boehringer Ingelheim gets first approval within E.U. for Actilyse

June 2, 2008

FDA approves Entereg for management of postoperative ileus

May 21, 2008

Prepandrix pre-pandemic influenza vaccine approved in Europe

May 20, 2008

Taflotan approved in Denmark for glaucoma and ocular hypertension

May 8, 2008

Febuxostat receives E.U. marketing authorization for hyperuricemia in gout

May 6, 2008

Sucampo obtains FDA approval for Amitiza for IBS with constipation in adult women

April 30, 2008

FDA approves Vyvanse to treat adult ADHD

April 25, 2008

Treximet receives FDA approval for acute treatment of migraine

April 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.